FDA will not fire staff pending Congress' move
This article was originally published in Clinica
Executive Summary
As the US Congress left last week for its month-long recess without passing a major Food and Drug Administration reform bill, FDA Commissioner Andrew von Eschenbach vowed that the FDA would use reserve funds rather than layoff employees. House and Senate leaders could not agree on a reform bill, which contains numerous post-market safety changes as well as reauthorisation for medical device and drug user fee programmes, and so the law requires the agency FDA to begin sending "reduction in force" notices to employees paid by those programmes.